Impact of induced pluripotent stem cells on the study of central nervous system disease

Current Opinion in Genetics and Development

Volumn 21, Issue 3, 2011, Pages 354-361

  Cundiff, Paige E ^a   Anderson, Stewart A ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; AUTISM; CELL DIFFERENTIATION; CELL TRANSFORMATION; CELL TYPE; CENTRAL NERVOUS SYSTEM DISEASE; DYSAUTONOMIA; EMBRYONIC STEM CELL; EPIGENETICS; FRAGILE X SYNDROME; GENE MUTATION; GENOME IMPRINTING; GENOTYPE ENVIRONMENT INTERACTION; HAPPY PUPPET SYNDROME; HUMAN; MENTAL DISEASE; MOLECULAR PATHOLOGY; NONHUMAN; NUCLEAR REPROGRAMMING; OXIDATIVE STRESS; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRADER WILLI SYNDROME; PRIORITY JOURNAL; RETT SYNDROME; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SOMATIC CELL; SPINAL MUSCULAR ATROPHY; STEM CELL TRANSPLANTATION; TREATMENT INDICATION;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANGELMAN SYNDROME; CENTRAL NERVOUS SYSTEM DISEASES; DYSAUTONOMIA, FAMILIAL; FRAGILE X SYNDROME; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MUSCULAR ATROPHY, SPINAL; NEURONS; PARKINSON DISEASE; PRADER-WILLI SYNDROME; RETT SYNDROME;

EID: 79956205399     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2011.01.008     Document Type: Review

References (74)

1. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
2. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
3. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., Bernstein B.E., Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent es-cell-like state. Nature 2007, 448:318-324.
4. Stadtfeld M., Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Genes Dev 2010, 24:2239-2263.
5. Hanna J.H., Saha K., Jaenisch R. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 2010, 143:508-525.
6. Ichida J.K., Blanchard J., Lam K., Son E.Y., Chung J.E., Egli D., Loh K.M., Carter A.C., Di Giorgio F.P., Koszka K., et al. A small-molecule inhibitor of tgf-beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 2009, 5:491-503.
7. Lyssiotis C.A., Foreman R.K., Staerk J., Garcia M., Mathur D., Markoulaki S., Hanna J., Lairson L.L., Charette B.D., Bouchez L.C., et al. Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of klf4. Proc Natl Acad Sci U S A 2009, 106:8912-8917.
8. Wernig M., Lengner C.J., Hanna J., Lodato M.A., Steine E., Foreman R., Staerk J., Markoulaki S., Jaenisch R. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol 2008, 26:916-924.
9. Kim J.B., Zaehres H., Wu G., Gentile L., Ko K., Sebastiano V., Arauzo-Bravo M.J., Ruau D., Han D.W., Zenke M., Scholer H.R. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008, 454:646-650.
10. Yang W.C., Patel K.G., Lee J., Ghebremariam Y.T., Wong H.E., Cooke J.P., Swartz J.R. Cell-free production of transducible transcription factors for nuclear reprogramming. Biotechnol Bioeng 2009, 104:1047-1058.
11. Hanna J., Saha K., Pando B., van Zon J., Lengner C.J., Creyghton M.P., van Oudenaarden A., Jaenisch R. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009, 462:595-601.
12. Feng B., Ng J.H., Heng J.C., Ng H.H. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 2009, 4:301-312.
13. Feng B., Jiang J., Kraus P., Ng J.H., Heng J.C., Chan Y.S., Yaw L.P., Zhang W., Loh Y.H., Han J., et al. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor esrrb. Nat Cell Biol 2009, 11:197-203.
14. Silva J., Barrandon O., Nichols J., Kawaguchi J., Theunissen T.W., Smith A. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol 2008, 6:e253.
15. Warren L., Manos P.D., Ahfeldt T., Loh Y.H., Li H., Lau F., Ebina W., Mandal P.K., Smith Z.D., Meissner A., et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mrna. Cell Stem Cell 2010, 7:618-630.
16. Hotta A., Cheung A.Y., Farra N., Vijayaragavan K., Seguin C.A., Draper J.S., Pasceri P., Maksakova I.A., Mager D.L., Rossant J., et al. Isolation of human ips cells using eos lentiviral vectors to select for pluripotency. Nat Methods 2009, 6:370-376.
17. Marchetto M.C., Carromeu C., Acab A., Yu D., Yeo G.W., Mu Y., Chen G., Gage F.H., Muotri A.R. A model for neural development and treatment of rett syndrome using human induced pluripotent stem cells. Cell 2010, 143:527-539.
18. Urbach A., Bar-Nur O., Daley G.Q., Benvenisty N. Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 2010, 6:407-411.
19. Chamberlain S.J., Chen P.F., Ng K.Y., Bourgois-Rocha F., Lemtiri-Chlieh F., Levine E.S., Lalande M. Induced pluripotent stem cell models of the genomic imprinting disorders angelman and prader-willi syndromes. Proc Natl Acad Sci U S A 2010, 107:17668-17673.
20. Ebert A.D., Yu J., Rose F.F., Mattis V.B., Lorson C.L., Thomson J.A., Svendsen C.N. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009, 457:277-280.
21. Marchetto M.C., Winner B., Gage F.H. Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases. Hum Mol Genet 2010, 19:R71-76.
22. Lee G., Papapetrou E.P., Kim H., Chambers S.M., Tomishima M.J., Fasano C.A., Ganat Y.M., Menon J., Shimizu F., Viale A., et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific ipscs. Nature 2009, 461:402-406.
23. Park I.H., Arora N., Huo H., Maherali N., Ahfeldt T., Shimamura A., Lensch M.W., Cowan C., Hochedlinger K., Daley G.Q. Disease-specific induced pluripotent stem cells. Cell 2008, 134:877-886.
24. Amir R.E., Zoghbi H.Y. Rett syndrome: methyl-cpg-binding protein 2 mutations and phenotype-genotype correlations. Am J Med Genet 2000, 97:147-152.
25. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in x-linked mecp2, encoding methyl-cpg-binding protein 2. Nat Genet 1999, 23:185-188.
26. Lasalle J.M., Yasui D.H. Evolving role of mecp2 in rett syndrome and autism. Epigenomics 2009, 1:119-130.
27. Nagarajan R.P., Patzel K.A., Martin M., Yasui D.H., Swanberg S.E., Hertz-Picciotto I., Hansen R.L., Van de Water J., Pessah I.N., Jiang R., et al. Mecp2 promoter methylation and X chromosome inactivation in autism. Autism Res 2008, 1:169-178.
28. Deng J., Shoemaker R., Xie B., Gore A., LeProust E.M., Antosiewicz-Bourget J., Egli D., Maherali N., Park I.H., Yu J., et al. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol 2009, 27:353-360.
29. Colman A., Dreesen O. Pluripotent stem cells and disease modeling. Cell Stem Cell 2009, 5:244-247.
30. Colman A., Dreesen O. Induced pluripotent stem cells and the stability of the differentiated state. EMBO Rep 2009, 10:714-721.
31. Chao H.T., Chen H., Samaco R.C., Xue M., Chahrour M., Yoo J., Neul J.L., Gong S., Lu H.C., Heintz N., et al. Dysfunction in gaba signalling mediates autism-like stereotypies and rett syndrome phenotypes. Nature 2010, 468:263-269.
32. Cuajungco M.P., Leyne M., Mull J., Gill S.P., Lu W., Zagzag D., Axelrod F.B., Maayan C., Gusella J.F., Slaugenhaupt S.A. Tissue-specific reduction in splicing efficiency of ikbkap due to the major mutation associated with familial dysautonomia. Am J Hum Genet 2003, 72:749-758.
33. Soldner F., Hockemeyer D., Beard C., Gao Q., Bell G.W., Cook E.G., Hargus G., Blak A., Cooper O., Mitalipova M., et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009, 136:964-977.
34. Dimos J.T., Rodolfa K.T., Niakan K.K., Weisenthal L.M., Mitsumoto H., Chung W., Croft G.F., Saphier G., Leibel R., Goland R., et al. Induced pluripotent stem cells generated from patients with als can be differentiated into motor neurons. Science 2008, 321:1218-1221.
35. Jenner P. Oxidative stress as a cause of parkinson's disease. Acta Neurol Scand Suppl 1991, 136:6-15.
36. Zhang Y., Dawson V.L., Dawson T.M. Oxidative stress and genetics in the pathogenesis of parkinson's disease. Neurobiol Dis 2000, 7:240-250.
37. Hargus G., Cooper O., Deleidi M., Levy A., Lee K., Marlow E., Yow A., Soldner F., Hockemeyer D., Hallett P.J., et al. Differentiated parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in parkinsonian rats. Proc Natl Acad Sci U S A 2010, 107:15921-15926.
38. Hu B.Y., Weick J.P., Yu J., Ma L.X., Zhang X.Q., Thomson J.A., Zhang S.C. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A 2010, 107:4335-4340.
39. Watanabe K., Kamiya D., Nishiyama A., Katayama T., Nozaki S., Kawasaki H., Watanabe Y., Mizuseki K., Sasai Y. Directed differentiation of telencephalic precursors from embryonic stem cells. Nat Neurosci 2005, 8:288-296.
40. Gaspard N., Bouschet T., Herpoel A., Naeije G., van den Ameele J., Vanderhaeghen P. Generation of cortical neurons from mouse embryonic stem cells. Nat Protoc 2009, 4:1454-1463.
41. Eiraku M., Watanabe K., Matsuo-Takasaki M., Kawada M., Yonemura S., Matsumura M., Wataya T., Nishiyama A., Muguruma K., Sasai Y. Self-organized formation of polarized cortical tissues from escs and its active manipulation by extrinsic signals. Cell Stem Cell 2008, 3:519-532.
42. Gaspard N., Bouschet T., Hourez R., Dimidschstein J., Naeije G., van den Ameele J., Espuny-Camacho I., Herpoel A., Passante L., Schiffmann S.N., et al. An intrinsic mechanism of corticogenesis from embryonic stem cells. Nature 2008, 455:351-357.
43. Kondo T., Sheets P.L., Zopf D.A., Aloor H.L., Cummins T.R., Chan R.J., Hashino E. Tlx3 exerts context-dependent transcriptional regulation and promotes neuronal differentiation from embryonic stem cells. Proc Natl Acad Sci U S A 2008, 105:5780-5785.
44. Conti L., Pollard S.M., Gorba T., Reitano E., Toselli M., Biella G., Sun Y., Sanzone S., Ying Q.L., Cattaneo E., Smith A. Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biol 2005, 3:e283.
45. Li X.J., Zhang X., Johnson M.A., Wang Z.B., Lavaute T., Zhang S.C. Coordination of sonic hedgehog and wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells. Development 2009, 136:4055-4063.
46. Maroof A.M., Brown K., Shi S.H., Studer L., Anderson S.A. Prospective isolation of cortical interneuron precursors from mouse embryonic stem cells. J Neurosci 2010, 30:4667-4675.
47. Spiliotopoulos D., Goffredo D., Conti L., Di Febo F., Biella G., Toselli M., Cattaneo E. An optimized experimental strategy for efficient conversion of embryonic stem (es)-derived mouse neural stem (ns) cells into a nearly homogeneous mature neuronal population. Neurobiol Dis 2009, 34:320-331.
48. Chatzi C., Scott R.H., Pu J., Lang B., Nakamoto C., McCaig C.D., Shen S. Derivation of homogeneous gabaergic neurons from mouse embryonic stem cells. Exp Neurol 2009, 217:407-416.
49. Wataya T., Ando S., Muguruma K., Ikeda H., Watanabe K., Eiraku M., Kawada M., Takahashi J., Hashimoto N., Sasai Y. Minimization of exogenous signals in es cell culture induces rostral hypothalamic differentiation. Proc Natl Acad Sci U S A 2008, 105:11796-11801.
50. Kawasaki H., Mizuseki K., Nishikawa S., Kaneko S., Kuwana Y., Nakanishi S., Nishikawa S.I., Sasai Y. Induction of midbrain dopaminergic neurons from es cells by stromal cell-derived inducing activity. Neuron 2000, 28:31-40.
51. Park C.H., Minn Y.K., Lee J.Y., Choi D.H., Chang M.Y., Shim J.W., Ko J.Y., Koh H.C., Kang M.J., Kang J.S., et al. In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons. J Neurochem 2005, 92:1265-1276.
52. Iacovitti L., Donaldson A.E., Marshall C.E., Suon S., Yang M. A protocol for the differentiation of human embryonic stem cells into dopaminergic neurons using only chemically defined human additives: Studies in vitro and in vivo. Brain Res 2007, 1127:19-25.
53. Cooper O., Hargus G., Deleidi M., Blak A., Osborn T., Marlow E., Lee K., Levy A., Perez-Torres E., Yow A., Isacson O. Differentiation of human es and parkinson's disease ips cells into ventral midbrain dopaminergic neurons requires a high activity form of shh, fgf8a and specific regionalization by retinoic acid. Mol Cell Neurosci 2010, 45:258-266.
54. Cho M.S., Lee Y.E., Kim J.Y., Chung S., Cho Y.H., Kim D.S., Kang S.M., Lee H., Kim M.H., Kim J.H., et al. Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A 2008, 105:3392-3397.
55. Ko J.Y., Park C.H., Koh H.C., Cho Y.H., Kyhm J.H., Kim Y.S., Lee I., Lee Y.S., Lee S.H. Human embryonic stem cell-derived neural precursors as a continuous, stable, and on-demand source for human dopamine neurons. J Neurochem 2007, 103:1417-1429.
56. Salero E., Hatten M.E. Differentiation of es cells into cerebellar neurons. Proc Natl Acad Sci U S A 2007, 104:2997-3002.
57. Su H.L., Muguruma K., Matsuo-Takasaki M., Kengaku M., Watanabe K., Sasai Y. Generation of cerebellar neuron precursors from embryonic stem cells. Dev Biol 2006, 290:287-296.
58. Erceg S., Ronaghi M., Zipancic I., Lainez S., Rosello M.G., Xiong C., Moreno-Manzano V., Rodriguez-Jimenez F.J., Planells R., Alvarez-Dolado M., et al. Efficient differentiation of human embryonic stem cells into functional cerebellar-like cells. Stem Cells Dev 2010, 19:1745-1756.
59. Lee H., Shamy G.A., Elkabetz Y., Schofield C.M., Harrsion N.L., Panagiotakos G., Socci N.D., Tabar V., Studer L. Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells 2007, 25:1931-1939.
60. Erceg S., Lainez S., Ronaghi M., Stojkovic P., Perez-Arago M.A., Moreno-Manzano V., Moreno-Palanques R., Planells-Cases R., Stojkovic M. Differentiation of human embryonic stem cells to regional specific neural precursors in chemically defined medium conditions. PLoS One 2008, 3:e2122.
61. Carpenter M.K., Inokuma M.S., Denham J., Mujtaba T., Chiu C.P., Rao M.S. Enrichment of neurons and neural precursors from human embryonic stem cells. Exp Neurol 2001, 172:383-397.
62. Wada T., Honda M., Minami I., Tooi N., Amagai Y., Nakatsuji N., Aiba K. Highly efficient differentiation and enrichment of spinal motor neurons derived from human and monkey embryonic stem cells. PLoS One 2009, 4:e6722.
63. Jiang P., Selvaraj V., Deng W. Differentiation of embryonic stem cells into oligodendrocyte precursors. J Vis Exp 2010, 39.
64. Billon N., Jolicoeur C., Raff M. Generation and characterization of oligodendrocytes from lineage-selectable embryonic stem cells in vitro. Methods Mol Biol 2006, 330:15-32.
65. Billon N., Jolicoeur C., Ying Q.L., Smith A., Raff M. Normal timing of oligodendrocyte development from genetically engineered, lineage-selectable mouse es cells. J Cell Sci 2002, 115:3657-3665.
66. Kerr C.L., Letzen B.S., Hill C.M., Agrawal G., Thakor N.V., Sterneckert J.L., Gearhart J.D., All A.H. Efficient differentiation of human embryonic stem cells into oligodendrocyte progenitors for application in a rat contusion model of spinal cord injury. Int J Neurosci 2010, 120:305-313.
67. Kishi N., Macklis J.D. Mecp2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci 2004, 27:306-321.
68. Shahbazian M.D., Zoghbi H.Y. Rett syndrome and mecp2: linking epigenetics and neuronal function. Am J Hum Genet 2002, 71:1259-1272.
69. Swaab D.F., Purba J.S., Hofman M.A. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J Clin Endocrinol Metab 1995, 80:573-579.
70. Albrecht U., Sutcliffe J.S., Cattanach B.M., Beechey C.V., Armstrong D., Eichele G., Beaudet A.L. Imprinted expression of the murine angelman syndrome gene, ube3a, in hippocampal and purkinje neurons. Nat Genet 1997, 17:75-78.
71. Dindot S.V., Antalffy B.A., Bhattacharjee M.B., Beaudet A.L. The angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum Mol Genet 2008, 17:111-118.
72. Fasano C.A., Phoenix T.N., Kokovay E., Lowry N., Elkabetz Y., Dimos J.T., Lemischka I.R., Studer L., Temple S. Bmi-1 cooperates with foxg1 to maintain neural stem cell self-renewal in the forebrain. Genes Dev 2009, 23:561-574.
73. Baraban S.C., Southwell D.G., Estrada R.C., Jones D.L., Sebe J.Y., Alfaro-Cervello C., Garcia-Verdugo J.M., Rubenstein J.L., Alvarez-Buylla A. Reduction of seizures by transplantation of cortical gabaergic interneuron precursors into kv1.1 mutant mice. Proc Natl Acad Sci U S A 2009, 106:15472-15477.
74. Martinez-Cerdeno V., Noctor S.C., Espinosa A., Ariza J., Parker P., Orasji S., Daadi M.M., Bankiewicz K., Alvarez-Buylla A., Kriegstein A.R. Embryonic mge precursor cells grafted into adult rat striatum integrate and ameliorate motor symptoms in 6-ohda-lesioned rats. Cell Stem Cell 2010, 6:238-250.